BIOHARVEST SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.235 CAD | 0.00% |
|
-9.62% | +9.30% |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Capitalization 1 | 78.51 | 165 | 98.54 | 77.63 |
| Enterprise Value (EV) 1 | 79.44 | 163.6 | 107.4 | 94.62 |
| P/E ratio | -9.12 x | -16.1 x | -8.7 x | -6.11 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | 198 x | 78.5 x | 17.9 x | 6.13 x |
| EV / Revenue | 201 x | 77.8 x | 19.5 x | 7.47 x |
| EV / EBITDA | -14.4 x | -19.4 x | -10.4 x | -9.88 x |
| EV / FCF | -22 x | -42.8 x | -15.2 x | -18.6 x |
| FCF Yield | -4.54% | -2.34% | -6.6% | -5.36% |
| Price to Book | -31.6 x | 57.8 x | -16.6 x | -5.23 x |
| Nbr of stocks (in thousands) | 444,455 | 453,630 | 460,716 | 478,688 |
| Reference price 2 | 0.1766 | 0.3638 | 0.2139 | 0.1622 |
| Announcement Date | 29/04/21 | 28/04/22 | 27/04/23 | 30/04/24 |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.449 | 0.218 | 0.396 | 2.102 | 5.498 | 12.67 |
| EBITDA 1 | -2.515 | -2.247 | -5.519 | -8.426 | -10.33 | -9.126 |
| EBIT 1 | -2.585 | -2.31 | -5.567 | -8.491 | -10.61 | -9.966 |
| Operating Margin | -575.72% | -1,059.63% | -1,405.81% | -403.95% | -193.02% | -78.65% |
| Earnings before Tax (EBT) 1 | -7.472 | -5.31 | -6.584 | -9.827 | -11.24 | -12.56 |
| Net income 1 | -6.673 | -4.27 | -6.584 | -9.827 | -11.24 | -12.56 |
| Net margin | -1,486.19% | -1,958.72% | -1,662.63% | -467.51% | -204.37% | -99.15% |
| EPS 2 | -0.7075 | -0.3400 | -0.0194 | -0.0226 | -0.0246 | -0.0265 |
| Free Cash Flow 1 | 0.1132 | -2.076 | -3.604 | -3.826 | -7.086 | -6.311 |
| FCF margin | 25.22% | -952.24% | -910.04% | -182.02% | -128.88% | -49.8% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 21/04/20 | 29/04/20 | 29/04/21 | 28/04/22 | 27/04/23 | 30/04/24 |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 18.1 | 23.1 | 0.93 | - | 8.82 | 17 |
| Net Cash position 1 | - | - | - | 1.46 | - | - |
| Leverage (Debt/EBITDA) | -7.183 x | -10.29 x | -0.1689 x | - | -0.8543 x | -1.774 x |
| Free Cash Flow 1 | 0.11 | -2.08 | -3.6 | -3.83 | -7.09 | -5.08 |
| ROE (net income / shareholders' equity) | 35.3% | 21.4% | 45% | -3,510% | 731% | 121% |
| ROA (Net income/ Total Assets) | -90.1% | -73.7% | -95% | -68.4% | -67.7% | -51.1% |
| Assets 1 | 7.41 | 5.791 | 6.931 | 14.36 | 16.6 | 24.6 |
| Book Value Per Share 2 | -2.790 | -3.240 | -0.0100 | 0.0100 | -0.0100 | -0.0300 |
| Cash Flow per Share 2 | 0.1300 | 0.1000 | 0 | 0.0100 | 0 | 0.0100 |
| Capex 1 | 0.05 | 0.03 | 0.17 | 1.64 | 1.26 | 1.47 |
| Capex / Sales | 11.8% | 15.6% | 43.69% | 78.02% | 22.84% | 11.63% |
| Announcement Date | 21/04/20 | 29/04/20 | 29/04/21 | 28/04/22 | 27/04/23 | 30/04/24 |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +9.30% | 98.72M | |
| +15.45% | 8.33B | |
| +3.59% | 7.73B | |
| +15.12% | 6.83B | |
| -5.87% | 3.78B | |
| +5.27% | 1.45B | |
| -30.67% | 1.06B | |
| +21.35% | 1.05B | |
| -13.58% | 882M | |
| -19.00% | 778M |
- Stock Market
- Equities
- BHSC Stock
- Financials BioHarvest Sciences Inc.
